In this regard, prostate-specific membrane antigen (PSMA), a transmembrane protein with a significantly increased expression in PCa cells, is an imaging probe that has been introduced in clinical practice, with recent data demonstrating good accuracy in PCa staging [11,12]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.